search
Boehringer Ingelheim
Trends
- 1Boehringer Ingelheim shares biopharmaceutical technology transfer insights▼Technology transfer expert insights | BioXcellence
Boehringer Ingelheim's BioXcellence platform has released expert insights on technology transfer in biopharmaceutical manufacturing. The material is aimed at companies moving biological production processes between sites or partners, a critical step in scaling up biologics and contract manufacturing. The topic is of interest to industry professionals navigating complex regulatory and operational requirements in biopharma production.
- 2
German pharmaceutical company Boehringer Ingelheim has announced plans to invest EUR 500 million in sustainability initiatives and health partnerships. The commitment, disclosed in a company announcement, is aimed at supporting environmental goals and expanding access to healthcare. Details on how the funds will be allocated across projects and partner organisations were not specified in the announcement.